Peregrine Capital Management LLC Dexcom Inc Transaction History

Peregrine Capital Management LLC

  • $3.18 Billion
  • Q3 2024

A detailed history of Peregrine Capital Management LLC transactions in Dexcom Inc stock. As of the latest transaction made, Peregrine Capital Management LLC holds 617,883 shares of DXCM stock, worth $46.9 Million. This represents 1.3% of its overall portfolio holdings.

Number of Shares
617,883
Previous 688,502 10.26%
Holding current value
$46.9 Million
Previous $78.1 Million 46.95%
% of portfolio
1.3%
Previous 2.36%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024
SELL
$64.0 - $116.06 $4.52 Million - $8.2 Million
-70,619 Reduced 10.26%
617,883 $41.4 Million
Q2 2024

Jul 29, 2024
BUY
$110.31 - $140.45 $1.55 Million - $1.97 Million
14,031 Added 2.08%
688,502 $78.1 Million
Q1 2024

Apr 26, 2024
SELL
$114.22 - $140.1 $1.29 Million - $1.59 Million
-11,336 Reduced 1.65%
674,471 $93.5 Million
Q4 2023

Jan 26, 2024
BUY
$75.49 - $124.16 $3.1 Million - $5.09 Million
41,014 Added 6.36%
685,807 $85.1 Million
Q3 2023

Oct 19, 2023
BUY
$86.06 - $137.93 $5.74 Million - $9.2 Million
66,703 Added 11.54%
644,793 $60.2 Million
Q2 2023

Jul 26, 2023
SELL
$112.47 - $130.98 $717,108 - $835,128
-6,376 Reduced 1.09%
578,090 $74.3 Million
Q1 2023

Apr 26, 2023
BUY
$104.0 - $122.92 $724,568 - $856,383
6,967 Added 1.21%
584,466 $67.9 Million
Q4 2022

Jan 10, 2023
BUY
$84.98 - $122.67 $749,268 - $1.08 Million
8,817 Added 1.55%
577,499 $65.4 Million
Q3 2022

Oct 26, 2022
SELL
$76.35 - $94.18 $597,744 - $737,335
-7,829 Reduced 1.36%
568,682 $45.8 Million
Q2 2022

Jul 20, 2022
BUY
$67.99 - $132.89 $28.9 Million - $56.4 Million
424,436 Added 279.1%
576,511 $43 Million
Q1 2022

Apr 27, 2022
SELL
$94.08 - $130.2 $1.28 Million - $1.77 Million
-13,604 Reduced 8.21%
152,075 $77.8 Million
Q4 2021

Jan 31, 2022
BUY
$129.87 - $162.82 $1.83 Million - $2.3 Million
14,097 Added 9.3%
165,679 $89 Million
Q3 2021

Nov 02, 2021
SELL
$106.71 - $143.18 $112,899 - $151,484
-1,058 Reduced 0.69%
151,582 $82.9 Million
Q2 2021

Aug 03, 2021
BUY
$80.99 - $107.93 $561,503 - $748,278
6,933 Added 4.76%
152,640 $65.2 Million
Q1 2021

May 11, 2021
BUY
$84.79 - $104.74 $3.11 Million - $3.85 Million
36,732 Added 33.71%
145,707 $52.4 Million
Q4 2020

Jan 19, 2021
BUY
$78.0 - $104.5 $1.08 Million - $1.44 Million
13,795 Added 14.49%
108,975 $40.3 Million
Q3 2020

Oct 20, 2020
BUY
$95.51 - $112.95 $55,013 - $65,059
576 Added 0.61%
95,180 $9.81 Million
Q2 2020

Jul 30, 2020
SELL
$62.68 - $105.34 $549,139 - $922,883
-8,761 Reduced 8.48%
94,604 $9.59 Million
Q1 2020

Apr 17, 2020
BUY
$47.79 - $75.63 $583,707 - $923,744
12,214 Added 13.4%
103,365 $6.96 Million
Q4 2019

Jan 16, 2020
SELL
$36.62 - $57.29 $7.32 Million - $11.4 Million
-199,800 Reduced 68.67%
91,151 $4.99 Million
Q3 2019

Oct 16, 2019
BUY
$35.53 - $43.8 $3.03 Million - $3.73 Million
85,246 Added 41.44%
290,951 $10.9 Million
Q2 2019

Jul 18, 2019
SELL
$27.84 - $38.92 $676,706 - $946,028
-24,307 Reduced 10.57%
205,705 $0
Q1 2019

Apr 12, 2019
SELL
$28.07 - $38.18 $301,022 - $409,442
-10,724 Reduced 4.45%
230,012 $0
Q4 2018

Jan 17, 2019
BUY
$26.99 - $37.37 $532,269 - $736,973
19,721 Added 8.92%
240,736 $7.21 Million
Q3 2018

Oct 18, 2018
SELL
$23.35 - $36.72 $1.68 Million - $2.63 Million
-71,740 Reduced 24.51%
221,015 $0
Q2 2018

Jul 12, 2018
BUY
$17.54 - $25.22 $256,715 - $369,119
14,636 Added 5.26%
292,755 $0
Q1 2018

Apr 16, 2018
SELL
$13.06 - $18.54 $125,519 - $178,187
-9,611 Reduced 3.34%
278,119 $0
Q4 2017

Jan 24, 2018
SELL
$11.12 - $15.38 $1.2 Million - $1.66 Million
-107,725 Reduced 27.24%
287,730 $0
Q3 2017

Oct 25, 2017
BUY
$11.36 - $18.98 $4.49 Million - $7.51 Million
395,455
395,455 $0

Others Institutions Holding DXCM

# of Institutions
1,013
Shares Held
351M
Call Options Held
5.51M
Put Options Held
5.6M
View Full List

About DEXCOM INC

DXCM Quotes by TradingView
  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $29.3B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Peregrine Capital Management LLC Portfolio

Follow Peregrine Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peregrine Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peregrine Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email